Malignant transformation of wild-type but not plasminogen activator inhibitor-1 gene-deficient fibroblasts decreases cellular sensitivity to chemotherapy-mediated apoptosis
- 31 May 2005
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (7) , 1095-1100
- https://doi.org/10.1016/j.ejca.2005.02.010
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patientsBritish Journal of Cancer, 2003
- The biochemistry of apoptosisNature, 2000
- The plasminogen activation system in tumor growth, invasion, and metastasisCellular and Molecular Life Sciences, 2000
- Regulation of cell adhesion by PAI‐1APMIS, 1999
- Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularizationNature Medicine, 1998
- The urokinase-type plasminogen activator system in cancer metastasis: A reviewInternational Journal of Cancer, 1997
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Plasminogen activators and plasminogen activator inhibitors in blood and tumour fluids of patients with ovarian cancerEuropean Journal Of Cancer, 1994
- Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancerThe Lancet, 1994
- Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancerBreast Cancer Research and Treatment, 1993